These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1424522)

  • 1. In vitro activity of mersacidin (M87-1551), an investigational peptide antibiotic tested against gram-positive bloodstream isolates.
    Barrett MS; Wenzel RP; Jones RN
    Diagn Microbiol Infect Dis; 1992; 15(7):641-4. PubMed ID: 1424522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin.
    Niu WW; Neu HC
    Antimicrob Agents Chemother; 1991 May; 35(5):998-1000. PubMed ID: 1649577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources.
    Jensen KT; Schønheyder H; Pers C; Thomsen VF
    APMIS; 1992 Jun; 100(6):543-52. PubMed ID: 1535201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of 43 antimicrobial agents tested against ampicillin-resistant enterococci and gram-positive species resistant to vancomycin.
    Yamane N; Jones RN
    Diagn Microbiol Infect Dis; 1991; 14(4):337-45. PubMed ID: 1889183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against gram-positive organisms.
    Benson CA; Beaudette F; Trenholm G
    J Antimicrob Chemother; 1987 Aug; 20(2):191-6. PubMed ID: 2822645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A; Colao MG; Orsi A; Dei R; Giganti E; Parenti F
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates.
    King A; Phillips I
    J Antimicrob Chemother; 2001 Aug; 48(2):219-23. PubMed ID: 11481291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms.
    Collins LA; Malanoski GJ; Eliopoulos GM; Wennersten CB; Ferraro MJ; Moellering RC
    Antimicrob Agents Chemother; 1993 Mar; 37(3):598-601. PubMed ID: 8460927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer.
    Rolston KV; Nguyen H; Messer M
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2137-41. PubMed ID: 2149921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States.
    Jones RN; Goldstein FW; Zhou XY
    Antimicrob Agents Chemother; 1991 Mar; 35(3):584-6. PubMed ID: 1828137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.
    Biavasco F; Lupidi R; Varaldo PE
    Antimicrob Agents Chemother; 1992 Feb; 36(2):331-8. PubMed ID: 1534977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms.
    Collins LA; Eliopoulos GM; Wennersten CB; Ferraro MJ; Moellering RC
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1364-6. PubMed ID: 8328787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol.
    Jones RN; Fritsche TR; Sader HS; Goldstein BP
    J Chemother; 2005 Dec; 17(6):593-600. PubMed ID: 16433188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of decaplanin (M86-1410), a new glycopeptide antibiotic.
    Sanchez ML; Wenzel RP; Jones RN
    Antimicrob Agents Chemother; 1992 Apr; 36(4):873-5. PubMed ID: 1386973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in gram-positive bloodstream organism resistance: a seven-year audit of five glycopeptides and other drugs at a large university hospital.
    Ena J; Houston A; Wenzel RP; Jones RN
    J Chemother; 1993 Feb; 5(1):17-21. PubMed ID: 8459260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO. Antimicrobial activity studies against gram-positive species.
    Johnson DM; Jones RN
    Diagn Microbiol Infect Dis; 1996 Jan; 24(1):53-7. PubMed ID: 8988765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.
    Urban C; Mariano N; Mosinka-Snipas K; Wadee C; Chahrour T; Rahal JJ
    J Antimicrob Chemother; 1996 Feb; 37(2):361-4. PubMed ID: 8707748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients.
    Rolston KV; Kapadia M; Tarrand J; Coyle E; Prince RA
    Int J Antimicrob Agents; 2013 Jun; 41(6):516-20. PubMed ID: 23481658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients.
    Rolston K; Wang W; Nesher L; Coyle E; Shelburne S; Prince RA
    J Antibiot (Tokyo); 2014 Jul; 67(7):505-9. PubMed ID: 24824818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of daptomycin tested against gram-positive strains collected in European hospitals: results from 7 years of resistance surveillance (2003-2009).
    Sader HS; Farrell DJ; Jones RN
    J Chemother; 2011 Aug; 23(4):200-6. PubMed ID: 21803696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.